1 Durvalumab Market Overview 1.1 Durvalumab Product Overview 1.2 Durvalumab Market Segment by Type 1.2.1 2.4mL Injection 1.2.2 10mL Injection 1.3 Global Durvalumab Market Size by Type 1.3.1 Global Durvalumab Market Size Overview by Type (2016-2027) 1.3.2 Global Durvalumab Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Durvalumab Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Durvalumab Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Durvalumab Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Durvalumab Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Durvalumab Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Durvalumab Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Durvalumab Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Durvalumab Sales Breakdown by Type (2016-2021) 1.4.2 Europe Durvalumab Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Durvalumab Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Durvalumab Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Durvalumab Sales Breakdown by Type (2016-2021) 2 Global Durvalumab Market Competition by Company 2.1 Global Top Players by Durvalumab Sales (2016-2021) 2.2 Global Top Players by Durvalumab Revenue (2016-2021) 2.3 Global Top Players Durvalumab Price (2016-2021) 2.4 Global Top Manufacturers Durvalumab Manufacturing Base Distribution, Sales Area, Product Type 2.5 Durvalumab Market Competitive Situation and Trends 2.5.1 Durvalumab Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Durvalumab Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Durvalumab as of 2020) 2.7 Date of Key Manufacturers Enter into Durvalumab Market 2.8 Key Manufacturers Durvalumab Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Durvalumab Status and Outlook by Region 3.1 Global Durvalumab Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Durvalumab Historic Market Size by Region 3.2.1 Global Durvalumab Sales in Volume by Region (2016-2021) 3.2.2 Global Durvalumab Sales in Value by Region (2016-2021) 3.2.3 Global Durvalumab Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Durvalumab Forecasted Market Size by Region 3.3.1 Global Durvalumab Sales in Volume by Region (2022-2027) 3.3.2 Global Durvalumab Sales in Value by Region (2022-2027) 3.3.3 Global Durvalumab Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Durvalumab by Application 4.1 Durvalumab Market Segment by Application 4.1.1 Locally Advanced Urothelial Carcinoma 4.1.2 Metastatic Urothelial Carcinoma 4.1.3 Other 4.2 Global Durvalumab Market Size by Application 4.2.1 Global Durvalumab Market Size Overview by Application (2016-2027) 4.2.2 Global Durvalumab Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Durvalumab Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Durvalumab Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Durvalumab Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Durvalumab Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Durvalumab Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Durvalumab Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Durvalumab Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Durvalumab Sales Breakdown by Application (2016-2021) 4.3.2 Europe Durvalumab Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Durvalumab Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Durvalumab Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Durvalumab Sales Breakdown by Application (2016-2021) 5 North America Durvalumab by Country 5.1 North America Durvalumab Historic Market Size by Country 5.1.1 North America Durvalumab Sales in Volume by Country (2016-2021) 5.1.2 North America Durvalumab Sales in Value by Country (2016-2021) 5.2 North America Durvalumab Forecasted Market Size by Country 5.2.1 North America Durvalumab Sales in Volume by Country (2022-2027) 5.2.2 North America Durvalumab Sales in Value by Country (2022-2027) 6 Europe Durvalumab by Country 6.1 Europe Durvalumab Historic Market Size by Country 6.1.1 Europe Durvalumab Sales in Volume by Country (2016-2021) 6.1.2 Europe Durvalumab Sales in Value by Country (2016-2021) 6.2 Europe Durvalumab Forecasted Market Size by Country 6.2.1 Europe Durvalumab Sales in Volume by Country (2022-2027) 6.2.2 Europe Durvalumab Sales in Value by Country (2022-2027) 7 Asia-Pacific Durvalumab by Region 7.1 Asia-Pacific Durvalumab Historic Market Size by Region 7.1.1 Asia-Pacific Durvalumab Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Durvalumab Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Durvalumab Forecasted Market Size by Region 7.2.1 Asia-Pacific Durvalumab Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Durvalumab Sales in Value by Region (2022-2027) 8 Latin America Durvalumab by Country 8.1 Latin America Durvalumab Historic Market Size by Country 8.1.1 Latin America Durvalumab Sales in Volume by Country (2016-2021) 8.1.2 Latin America Durvalumab Sales in Value by Country (2016-2021) 8.2 Latin America Durvalumab Forecasted Market Size by Country 8.2.1 Latin America Durvalumab Sales in Volume by Country (2022-2027) 8.2.2 Latin America Durvalumab Sales in Value by Country (2022-2027) 9 Middle East and Africa Durvalumab by Country 9.1 Middle East and Africa Durvalumab Historic Market Size by Country 9.1.1 Middle East and Africa Durvalumab Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Durvalumab Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Durvalumab Forecasted Market Size by Country 9.2.1 Middle East and Africa Durvalumab Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Durvalumab Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Durvalumab Business 10.1 Medimmune (AstraZeneca) 10.1.1 Medimmune (AstraZeneca) Corporation Information 10.1.2 Medimmune (AstraZeneca) Introduction and Business Overview 10.1.3 Medimmune (AstraZeneca) Durvalumab Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Medimmune (AstraZeneca) Durvalumab Products Offered 10.1.5 Medimmune (AstraZeneca) Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Durvalumab Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Durvalumab Industrial Chain Analysis 11.4 Durvalumab Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Durvalumab Distributors 12.3 Durvalumab Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 2.4mL Injection Table 2. Major Company of 10mL Injection Table 3. Global Durvalumab Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Durvalumab Sales by Type (2016-2021) & (K Pcs) Table 5. Global Durvalumab Sales Market Share in Volume by Type (2016-2021) Table 6. Global Durvalumab Sales by Type (2016-2021) & (US& Million) Table 7. Global Durvalumab Market Share in Value by Type (2016-2021) Table 8. Global Durvalumab Price by Type (2016-2021) & (USD/Pcs) Table 9. Global Durvalumab Sales by Type (2022-2027) & (K Pcs) Table 10. Global Durvalumab Sales Market Share in Volume by Type (2022-2027) Table 11. Global Durvalumab Sales by Type (2022-2027) & (US$ Million) Table 12. Global Durvalumab Sales Market Share in Value by Type (2022-2027) Table 13. Global Durvalumab Price by Type (2022-2027) & (USD/Pcs) Table 14. North America Durvalumab Sales by Type (2016-2021) & (K Pcs) Table 15. North America Durvalumab Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Durvalumab Sales (K Pcs) by Type (2016-2021) Table 17. Europe Durvalumab Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Durvalumab Sales (K Pcs) by Type (2016-2021) Table 19. Asia-Pacific Durvalumab Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Durvalumab Sales (K Pcs) by Type (2016-2021) Table 21. Latin America Durvalumab Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Durvalumab Sales (K Pcs) by Type (2016-2021) Table 23. Middle East and Africa Durvalumab Sales by Type (2016-2021) & (US$ Million) Table 24. Global Durvalumab Sales by Company (2016-2021) & (K Pcs) Table 25. Global Durvalumab Sales Share by Company (2016-2021) Table 26. Global Durvalumab Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Durvalumab Revenue Share by Company (2016-2021) Table 28. Global Market Durvalumab Price by Company (2016-2021) & (USD/Pcs) Table 29. Global Durvalumab Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Durvalumab Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Durvalumab as of 2020 Table 32. Date of Key Manufacturers Enter into Durvalumab Market Table 33. Key Manufacturers Durvalumab Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Durvalumab Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Durvalumab Sales by Region (2016-2021) & (K Pcs) Table 37. Global Durvalumab Sales Market Share in Volume by Region (2016-2021) Table 38. Global Durvalumab Sales by Region (2016-2021) & (US$ Million) Table 39. Global Durvalumab Sales Market Share in Value by Region (2016-2021) Table 40. Global Durvalumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 41. Global Durvalumab Sales by Region (2022-2027) & (K Pcs) Table 42. Global Durvalumab Sales Market Share in Volume by Region (2022-2027) Table 43. Global Durvalumab Sales by Region (2022-2027) & (US$ Million) Table 44. Global Durvalumab Sales Market Share in Value by Region (2022-2027) Table 45. Global Durvalumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 46. Global Durvalumab Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Durvalumab Sales by Application (2016-2021) & (K Pcs) Table 48. Global Durvalumab Sales Market Share in Volume by Application (2016-2021) Table 49. Global Durvalumab Sales by Application (2016-2021) & (US$ Million) Table 50. Global Durvalumab Sales Market Share in Value by Application (2016-2021) Table 51. Global Durvalumab Price by Application (2016-2021) & (USD/Pcs) Table 52. Global Durvalumab Sales by Application (2022-2027) & (K Pcs) Table 53. Global Durvalumab Sales Market Share in Volume by Application (2022-2027) Table 54. Global Durvalumab Sales by Application (2022-2027) & (US$ Million) Table 55. Global Durvalumab Sales Market Share in Value by Application (2022-2027) Table 56. Global Durvalumab Price by Application (2022-2027) & (USD/Pcs) Table 57. North America Durvalumab Sales by Application (2016-2021) (K Pcs) Table 58. North America Durvalumab Sales by Application (2016-2021) & (US$ Million) Table 59. North America Durvalumab Sales Market Share in Value by Application in 2020 Table 60. Europe Durvalumab Sales by Application (2016-2021) (K Pcs) Table 61. Europe Durvalumab Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Durvalumab Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Durvalumab Sales by Application (2016-2021) (K Pcs) Table 64. Asia-Pacific Durvalumab Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Durvalumab Sales Market Share in Value by Application in 2020 Table 66. Latin America Durvalumab Sales by Application (2016-2021) (K Pcs) Table 67. Latin America Durvalumab Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Durvalumab Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Durvalumab Sales by Application (2016-2021) (K Pcs) Table 70. Middle East and Africa Durvalumab Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Durvalumab Sales Market Share in Value by Application in 2020 Table 72. North America Durvalumab Sales by Country (2016-2021) & (K Pcs) Table 73. North America Durvalumab Sales Market Share in Volume by Country (2016-2021) Table 74. North America Durvalumab Sales by Country (2016-2021) & (US$ Million) Table 75. North America Durvalumab Sales Market Share in Value by Country (2016-2021) Table 76. North America Durvalumab Sales by Country (2022-2027) & (K Pcs) Table 77. North America Durvalumab Sales Market Share in Volume by Country (2022-2027) Table 78. North America Durvalumab Sales by Country (2022-2027) & (US$ Million) Table 79. North America Durvalumab Sales Market Share in Value by Country (2022-2027) Table 80. Europe Durvalumab Sales by Country (2016-2021) & (K Pcs) Table 81. Europe Durvalumab Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Durvalumab Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Durvalumab Sales Market Share in Value by Country (2016-2021) Table 84. Europe Durvalumab Sales by Country (2022-2027) & (K Pcs) Table 85. Europe Durvalumab Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Durvalumab Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Durvalumab Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Durvalumab Sales by Region (2016-2021) & (K Pcs) Table 89. Asia-Pacific Durvalumab Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Durvalumab Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Durvalumab Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Durvalumab Sales by Region (2022-2027) & (K Pcs) Table 93. Asia-Pacific Durvalumab Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Durvalumab Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Durvalumab Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Durvalumab Sales by Country (2016-2021) & (K Pcs) Table 97. Latin America Durvalumab Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Durvalumab Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Durvalumab Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Durvalumab Sales by Country (2022-2027) & (K Pcs) Table 101. Latin America Durvalumab Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Durvalumab Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Durvalumab Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Durvalumab Sales by Country (2016-2021) & (K Pcs) Table 105. Middle East and Africa Durvalumab Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Durvalumab Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Durvalumab Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Durvalumab Sales by Country (2022-2027) & (K Pcs) Table 109. Middle East and Africa Durvalumab Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Durvalumab Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Durvalumab Sales Market Share in Value by Country (2022-2027) Table 112. Medimmune (AstraZeneca) Corporation Information Table 113. Medimmune (AstraZeneca) Introduction and Business Overview Table 114. Medimmune (AstraZeneca) Durvalumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 115. Medimmune (AstraZeneca) Durvalumab Product Table 116. Medimmune (AstraZeneca) Recent Development Table 117. Key Raw Materials Lists Table 118. Raw Materials Key Suppliers Lists Table 119. Durvalumab Market Trends Table 120. Durvalumab Market Drivers Table 121. Durvalumab Market Challenges Table 122. Durvalumab Market Restraints Table 123. Durvalumab Distributors List Table 124. Durvalumab Downstream Customers Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Durvalumab Product Picture Figure 2. Global Durvalumab Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Durvalumab Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Durvalumab Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of 2.4mL Injection Figure 6. Global 2.4mL Injection Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of 10mL Injection Figure 8. Global 10mL Injection Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Global Durvalumab Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Durvalumab Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Durvalumab Sales Market Share in Value by Type (2016-2021) Figure 12. Global Durvalumab Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Durvalumab Sales Market Share in Value by Type (2022-2027) Figure 14. North America Durvalumab Sales Market Share in Volume by Type in 2020 Figure 15. North America Durvalumab Sales Market Share in Value by Type in 2020 Figure 16. Europe Durvalumab Sales Market Share in Volume by Type in 2020 Figure 17. Europe Durvalumab Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Durvalumab Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Durvalumab Sales Market Share in Value by Type in 2020 Figure 20. Latin America Durvalumab Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Durvalumab Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Durvalumab Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Durvalumab Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Durvalumab Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Durvalumab Revenue in 2020 Figure 26. Durvalumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Locally Advanced Urothelial Carcinoma Figure 28. Global Locally Advanced Urothelial Carcinoma Sales YoY Growth (2016-2027) & (K Pcs) Figure 29. Product Picture of Metastatic Urothelial Carcinoma Figure 30. Global Metastatic Urothelial Carcinoma Sales YoY Growth (2016-2027) & (K Pcs) Figure 31. Product Picture of Other Figure 32. Global Other Sales YoY Growth (2016-2027) & (K Pcs) Figure 33. Global Durvalumab Sales by Application (2016-2027) & (US$ Million) Figure 34. Global Durvalumab Sales Market Share in Volume by Application (2016-2021) Figure 35. Global Durvalumab Sales Market Share in Value by Application (2016-2021) Figure 36. Global Durvalumab Sales Market Share in Volume by Application (2022-2027) Figure 37. North America Durvalumab Sales Market Share in Volume by Application in 2020 Figure 38. Latin America Durvalumab Sales Market Share in Value by Application in 2020 Figure 39. Middle East and Africa Durvalumab Sales Market Share in Value by Application in 2020 Figure 40. Key Raw Materials Price Figure 41. Durvalumab Manufacturing Cost Structure Figure 42. Durvalumab Industrial Chain Analysis Figure 43. Channels of Distribution Figure 44. Distributors Profiles Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Medimmune (AstraZeneca)